Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.

Chessells, JM; Eden, OB; Bailey, CC; Lilleyman, JS; Richards, SM

Abstract:

Acute lymphoblastic leukaemia (ALL) is rare under 1 year and has a poor prognosis. Only 14 of 48 infants treated on two consecutive MRC UKALL trials remain alive in first remission. Forty infants have subsequently been treated on a protocol incorporating further intensification with an option for high-dose chemotherapy and autologous or allogeneic bone marrow transplantation. The results show no improvement over previous trials largely due to the number of remission deaths; four of nine being...

Expand abstract

Publication status:

Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Chessells, J. M., Eden, O. B., Bailey, C. C., Lilleyman, J. S., & Richards, S. M. (1994). Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia. Leukemia, 8(8), 1275–1279.

MLA Style

Chessells, J. M., et al. “Acute Lymphoblastic Leukaemia in Infancy: Experience in MRC UKALL Trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.” Leukemia, vol. 8, no. 8, 1994, pp. 1275–79.

Chicago Style

Chessells, JM, OB Eden, CC Bailey, JS Lilleyman, and SM Richards. 1994. “Acute Lymphoblastic Leukaemia in Infancy: Experience in MRC UKALL Trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.” Leukemia 8 (8): 1275–79.
Tweet
Print